| Sodium Intake, ACE Inhibition, and Progression to ESRD S Vegter, A Perna, MJ Postma, G Navis, G Remuzzi, P Ruggenenti Journal of the American Society of Nephrology 23 (1), 165-173, 2012 | 347 | 2012 |
| Clinical and economic impact of non-adherence in COPD: a systematic review JFM van Boven, NH Chavannes, T van der Molen, ... Respiratory medicine 108 (1), 103-113, 2014 | 265 | 2014 |
| A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe S Vegter, K Tolley PloS one 9 (6), e96829, 2014 | 131 | 2014 |
| Economic evaluations of pharmacogenetic and pharmacogenomic screening tests: a systematic review. Second update of the literature EJJ Berm, M Looff, B Wilffert, C Boersma, L Annemans, S Vegter, ... PloS one 11 (1), e0146262, 2016 | 125 | 2016 |
| Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines S Vegter, C Boersma, M Rozenbaum, B Wilffert, GJ Navis, MJ Postma Pharmacoeconomics 26, 569-587, 2008 | 112 | 2008 |
| Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis JFM van Boven, E Tommelein, K Boussery, E Mehuys, S Vegter, ... Respiratory research 15, 1-11, 2014 | 101 | 2014 |
| Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis JFM van Boven, LTW de Jong-van den Berg, S Vegter Drug safety 36, 231-236, 2013 | 96 | 2013 |
| Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence JFM van Boven, AGG Stuurman-Bieze, EG Hiddink, MJ Postma, S Vegter Journal of Managed Care Pharmacy 20 (8), 786-792, 2014 | 85 | 2014 |
| Misdiagnosis and mistreatment of a common side‐effect–angiotensin‐converting enzyme inhibitor‐induced cough S Vegter, LTW De Jong‐van den Berg British journal of clinical pharmacology 69 (2), 200-203, 2010 | 85 | 2010 |
| Persistence with osteoporosis medication among newly-treated osteoporotic patients JFM van Boven, PT de Boer, MJ Postma, S Vegter Journal of bone and mineral metabolism 31, 562-570, 2013 | 69 | 2013 |
| Costeffectiveness of varicella vaccination programs: an update of the literature MH Rozenbaum, AJ van Hoek, S Vegter, MJ Postma Expert review of vaccines 7 (6), 753-782, 2008 | 69 | 2008 |
| Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication AGG Stuurman-Bieze, EG Hiddink, JFM Van Boven, S Vegter Osteoporosis International 25, 1807-1812, 2014 | 65 | 2014 |
| COPD in the working age population: the economic impact on both patients and government JFM Van Boven, S Vegter, T Van Der Molen, MJ Postma COPD: Journal of Chronic Obstructive Pulmonary Disease 10 (6), 629-639, 2013 | 57 | 2013 |
| Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. S Vegter, NH Nguyen, ST Visser, LT de Jong-van den Berg, MJ Postma, ... The American journal of managed care 17 (9), 609, 2011 | 54* | 2011 |
| DIALYSIS. BONE DISEASE HPS RATE | 51 | 2015 |
| Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations S Vegter, MH Rozenbaum, R Postema, K Tolley, MJ Postma Clinical therapeutics 32 (9), 1651-1661, 2010 | 48 | 2010 |
| Proactive pharmaceutical care interventions improve patients’ adherence to lipid-lowering medication AGG Stuurman-Bieze, EG Hiddink, JFM Van Boven, S Vegter Annals of Pharmacotherapy 47 (11), 1448-1456, 2013 | 43 | 2013 |
| Meta‐analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis S Vegter, K Tolley, T Wilson Waterworth, H Jones, S Jones, D Jewell Alimentary pharmacology & therapeutics 38 (3), 284-293, 2013 | 43 | 2013 |
| Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis S Vegter, P Oosterhof, JFM van Boven, AGG Stuurman-Bieze, EG Hiddink, ... Journal of Managed Care Pharmacy 20 (7), 722-732, 2014 | 42 | 2014 |
| Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature S Vegter, E Jansen, MJ Postma, C Boersma Drug Development Research 71 (8), 492-501, 2010 | 36 | 2010 |
Mark RozenbaumPfizerVerified email at pfizer.com
